Evidence map›Paper›PMID 41481359›Full record

ArticleJournal of tropical pediatrics2026

Prevalence of multidrug-resistant organisms colonizing neonates at a tertiary hospital in Johannesburg, South Africa.

Nonkululeko Mntla, Vindana Chibabhai, Trusha Nana

Abstract read
In one paragraph

Article in Journal of tropical pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nonkululeko MntlaClinical Microbiology and Infectious Diseases, University of the Witwatersrand, Johannesburg, 2193, South Africa.ORCID 0000-0001-9031-7228
Vindana ChibabhaiClinical Microbiology and Infectious Diseases, University of the Witwatersrand, Johannesburg, 2193, South Africa.ORCID 0000-0002-5115-5999
Trusha NanaClinical Microbiology and Infectious Diseases, University of the Witwatersrand, Johannesburg, 2193, South Africa.ORCID 0000-0002-0216-1575

Funding

Bill and Melinda Gates Foundation and accessed through the WITS Vaccines and Infectious Diseases Analytics Research Unit (VIDA)National Health Laboratory Service (NHLS) PR20005
6 · The paper itself

Abstract

Neonatal mortality remains a global health challenge, particularly in sub-Saharan Africa, where infections often caused by multidrug-resistant (MDR) organisms are a leading cause of death. This study aimed to assess the prevalence of MDR ESKAPE pathogens and Candida auris colonization among hospitalized neonates in a non-outbreak setting, identify associated risk factors, and characterize antimicrobial resistance patterns. A cross-sectional sub-study was conducted at a tertiary hospital in South Africa between November and December 2020. A total of 258 rectal and skin swabs were collected from 86 neonates and cultured for ESKAPE organisms and C. auris. Isolated MDR organisms underwent further characterization. Of the 135 ESKAPE + C. auris isolates identified, 70.4% (95/135) were MDR. Colonization with ESBL-producing Klebsiella pneumoniae was most common (65%, 56/86), followed by XDR Acinetobacter baumannii. NDM-producing A. baumannii (5.8%) was more frequently detected than carbapenemase-producing Enterobacterales (3.9%). A prolonged hospital stay (median 14 days, P < .001) was significantly associated with MDR colonization. Rectal and skin swabs provided comparable yields for Gram-negative MDR organisms. The high prevalence of MDR ESKAPE + C. auris colonization highlights the value of routine, non-invasive screening for surveillance in neonatal units. Enhanced infection control strategies and improved surveillance systems incorporating colonization swabs and clinical risk profiling are urgently needed.

Indexed as

Anti-Bacterial AgentsCandida aurisCross InfectionDrug Resistance, Multiple, BacterialCross-Sectional StudiesFemaleHumansInfant, NewbornKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsPrevalenceRectumRisk FactorsSouth AfricaTertiary Care CentersAnti-Bacterial AgentsAcinetobacter baumanniibeta-lactamaseCandida auriscarbapenem resistantcolonizationKlebsiella pneumoniaeMRSAmultidrug resistanceneonateSouthern Africa

Identifiers

PMID41481359
PMCPMC12758378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.